+442031614272

info@adkaccountancy.com

MHRA statement on the PATHWAYS puberty blocker trial

News

With all complex clinical trials, MHRA’s top priority is the safety and wellbeing of the trial participants

Source link

Tags :
blocker,MHRA,PATHWAYS,puberty,statement,trial
Share This :